The global pharma contract sales market is expected to grow at a CAGR of 7.9% in the first half of the forecast period. In 2019, the contract detailing segment held 76% of the global pharma contract sales market.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 244-page report you will receive 77 tables and 62 figures– all unavailable elsewhere.
The 244-page report provides clear detailed insight into the global pharma contract sales market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Pharma Contract Sales Market forecasts from 2020-2030
• Along with revenue prediction for the overall world market for pharma contract sales market, our investigation shows forecasts to 2030 for the following submarket by leading services: • Contract detailing (personal promotion/field sales) • Contract non-personal promotion, with further sub-forecasting for teledetailing, eDetailing and others • Medical education services • Sample management services
• This report also breaks down the revenue forecast for pharma contract sales market by therapeutic segments: • Cardiovascular disease • Metabolic disorders • Oncology • Other
• This report provides individual revenue forecasts to 2030 for these regional and national markets: • US • Japan • EU5: Germany, UK, France, Italy and Spain • BRIC: China, India, Brazil and Russia
The US, Japan, EU5 and BRIC markets are further segmented by therapeutic segments and leading services
• Our study discusses the SWOT and STEP factors of the global pharma contract sales market
• Our study also discusses factors that will drive and restrain the global pharma contract sales market
• Our study discusses issues affecting the pharma contract sales industry and market: • Outsourced and in-house sales reps – trends and emerging sales models, including multiple channels (multichannel marketing to medical professionals) • Services CSOs offer and benefits to drug companies outsourcing medical sales • Maturing brands and product launches, including flexibility in field sales teams • Legislation and new market access requirements for pharma sales representatives • Changes to online marketing and potential for IT technologies Risk-sharing agreements • Key account management (KAM) and medical science liaison (MSL)
• This report discusses the leading companies in pharma contract sales: • Apodi • CMIC • inVentiv Health (Syneos Health) • IQVIA • Marvecs • OnCall, LLC • Publicis Healthcare Communications Group • Sofip • Star Healthcare • UDG Healthcare
• Key questions answered by this report: • How much is the global pharma contract sales market currently worth, and how much will it be worth during the period 2020-2030? • What are the leading therapeutic submarkets from 2020-2030? • What are the leading services submarkets from 2020-2030? • What are the leading national markets and the leading emerging markets from 2020-2030? What are the regulatory landscapes in these nations? • What are the main trends that will shape this market over the next ten years, and the main drivers and restraints? • Who are the leading CSOs in this market?
Visiongain’s study is intended for anyone requiring commercial analyses for the global pharma contract sales market. You find data, trends and predictions.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Pharma Contract Sales Overview
1.2 Why You Should Read This Report
1.3 How this Report Delivers
1.4 Main Questions Answered by this Report
1.5 Who is this Report for?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Reports
1.9 About Visiongain
2. Introduction to Pharma Contract Sales Market
2.1 Defining the Market
2.2 What is a CSO?
2.3 What Services do CSOs Provide?
2.4 Marketing Channels Employed by Pharma Companies in 2019
2.5 Growing Trend of Outsourcing in the Overall Pharma Industry
2.6 Detailing: Becoming Less Relevant or is it as Important as Ever?
2.6.1 Declining Access to Doctors: Trend Continues in 2019
2.7 Large Cuts in Sales Force in Various Companies
2.8 Companies Cannot Rely Solely Upon Detailing
2.8.1 Trends Driving the Need for New Sales Models
3. Global Pharma Contract Sales Market 2020-2030
3.1 The Market in 2019
3.2 Global Pharma Contract Sales Market 2018-2024
3.2.1 Growth in the Market in Recent Years
3.3 The Factors that Will Drive Growth in this Market: Advantages of Outsourcing Pharma Sales
3.3.1 Cost and Flexibility
3.3.2 New Technologies and Sales Models
3.3.3 Emerging Markets and Mature Brands
3.3.4 Biosimilars
3.3.5 Account Management, Medical Education and Patient Support Services
3.3.6 Market Access Complexities Provide its Own Opportunities for CSOs
3.3.7 New Drug Launches
3.3.8 Summary
3.4 The Factors that Will Restrain Growth in this Market: Disadvantages of Outsourcing Pharma Sales
3.5 Leading Therapeutic Submarkets for Pharma Contract Sales, Forecast 2020-2030
3.6 The Rise in Pharma Contract Sales
3.7 How Will the Therapeutic Composition of the Market Change Between 2019 and 2030?
3.8 Contract Sales for Cardiovascular Drugs
3.8.1 Current Status
3.8.2 Recent Cardiovascular Drug Patent Expiries and FDA Approvals
3.8.3 Cardiovascular and Cerebrovascular Conditions are the World’s Most Fatal Diseases
3.8.4 Contract Sales for Cardiovascular Drugs: Submarket Forecast 2020-2030
3.9 Contract Sales for Metabolic Disorder Drugs
3.9.1 Current Status
3.9.2 430 Million People Expected to be Diagnosed with Diabetes by 2030
3.9.3 Contract Sales for Metabolic Disorders: Submarket Forecast 2020-2030
3.10 Contract Sales for Oncology Drugs
3.10.1 Current Status
3.10.2 Patent Expiries and Recent Approvals
3.10.3 Contract Sales for Oncology Drugs Forecast 2020-2029
4. Leading Service Sectors of the Pharma Contract Sales Market 2020-2030
4.1 The Leading Services
4.1.1 Leading Service Sectors of the Market, Forecast 2020-2030
4.1.2 How Will the Service Composition over the Market Change over the Next Ten Years?
4.2 Contract Detailing Submarket
4.2.1 Are we in the Midst of a Turnaround in Sales Rep Numbers in the Overall Pharma Industry?
4.2.2 What are the Trends in Sales Reps Employed by CSOs?
4.2.3 Detailing Services Offered by CSOs
4.2.4 CSOs will be Impacted by Declining Physician Access as Much as In-House Reps
E-Clinical solution is an electronic medium of clinical study and research in pharmaceutical and biotechnical industry, the eClinical software helps...
Contract manufacturing represents the largest sector of the pharma outsourcing industry. Pharmaceutical companies have sought to take advantage of the...
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033
The global Automation in Biopharma Industry market was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033.
The global eClinical Solutions market was valued at US$8.03 billion in 2022 and is projected to grow at a CAGR of 13.09% during the forecast period 2023-2033.
The global Therapeutic Respiratory Devices market was valued at US$59.49 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.
Visiongain Publishes Regenerative Medicine Market Report 2023-2033
The global Regenerative Medicine market was valued at US$ 50.37 billion in 2022 and is projected to grow at a CAGR of 18.40% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
